31988-9 |
Western equine encephalitis virus Ag |
PrThr |
XXX |
Pt |
Ord |
|
|
ACTIVE |
Western equine encephalitis virus Ag [Presence] in Specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
31988-9 |
|
|
|
|
Both |
|
|
|
0 |
WEEV Ag Spec Ql |
|
|
|
N |
|
Antigen; Antigens; Enc; Enceph; Encephalomyelitis; Equin; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Togavirus; Unspecified; WEE virus; WEEV; West |
2.69 |
2.07 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
31989-7 |
14-3-3 Ag |
PrThr |
CSF |
Pt |
Ord |
|
|
ACTIVE |
14-3-3 Ag [Presence] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
31989-7 |
|
|
|
|
Both |
|
|
|
0 |
14-3-3 Ag CSF Ql |
|
|
|
N |
|
Antigen; Antigens; Cerebral spinal fluid; Cerebrospinal Fl; CJ; CJD; Creutzfeldt-Jacob Disease; Creutzfeldt-Jakob Disease; III; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.73 |
2.07 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
3199-7 |
Coagulation factor VII activity |
ACnc |
PPP |
Pt |
Qn |
Chromo |
|
ACTIVE |
Coagulation factor VII activity [Units/volume] in Platelet poor plasma by Chromogenic method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
COAG |
|
3199-7 |
|
Chromo |
|
|
Both |
|
|
|
0 |
Fact VII PPP Chro-aCnc |
|
|
|
Y |
|
Activ; Actvty; Arbitrary concentration; Chromogenic assay; Coag; ENZY; Enzymatic assay; F7; Fac; Fact; Fact VII; Factor 7; FVII; Hematology; Heme; Movements; Plas; Platelet poor plasma; Point in time; Proconvertin; QNT; Quan; Quant; Quantitative; Random; Serum prothrombin conversion accelerator; SPCA |
2.73 |
1 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
31990-5 |
14-3-3 Ag |
ACnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
14-3-3 Ag [Units/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
31990-5 |
|
|
|
|
Both |
|
|
|
0 |
14-3-3 Ag CSF-aCnc |
|
|
|
N |
|
Antigen; Antigens; Arbitrary concentration; Cerebral spinal fluid; Cerebrospinal Fl; CJ; CJD; Creutzfeldt-Jacob Disease; Creutzfeldt-Jakob Disease; III; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.69 |
2.07 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
31991-3 |
Acylcarnitine |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Acylcarnitine [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
31991-3 |
|
|
|
|
Both |
|
|
|
0 |
Acylcarnitine SerPl Ql |
|
|
|
N |
|
Acyl carnitine; Acylcarni; Chemistry; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.63 |
2.07 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. Order_Obs: changed from 'observation' to 'both' to reflect that the LOINC code can also be used as an order code. |
0 |
31992-1 |
Aldosterone |
MCnc |
Urine |
24H |
Qn |
|
|
ACTIVE |
Aldosterone [Mass/volume] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
ng/dL |
|
|
|
|
|
|
CHEM |
|
31992-1 |
|
|
|
|
Both |
|
|
|
0 |
Aldost 24h Ur-mCnc |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; Endocrine; Endocrinology; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn |
2.73 |
2.07 |
|
|
|
|
|
|
|
ng/dL |
|
|
|
0 |
31993-9 |
Alpha-1-Fetoprotein |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Alpha-1-Fetoprotein [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
31993-9 |
|
|
|
|
Both |
|
|
|
0 |
AFP SerPl Ql |
|
|
|
N |
|
A1; AFP; Alfa; Alpha fetoprotein; Alphafetoprotein; Chemistry; Feto; i; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker |
2.73 |
2.07 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
31994-7 |
Basophils/Leukocytes |
NFr |
Pericard fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Basophils/Leukocytes in Pericardial fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
31994-7 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Basophils NFr Pcar Manual |
|
|
|
N |
|
Baso; Basophil; Basos; Bph; Cardio; Cardiology; Heart Disease; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Pcar; Percent; Pericardial fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells |
2.79 |
2.07 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
31995-4 |
Basophils/Leukocytes |
NFr |
Plr fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Basophils/Leukocytes in Pleural fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
31995-4 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Basophils NFr Plr Manual |
|
|
|
N |
|
Baso; Basophil; Basos; Bph; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Pleural; Pleural fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; thoracentesis fluid; WBC; WBCs; White blood cell; White blood cells |
2.79 |
2.07 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
31996-2 |
Basophils/Leukocytes |
NFr |
Periton fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Basophils/Leukocytes in Peritoneal fluid by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
31996-2 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Basophils NFr Prt Manual |
|
|
|
N |
|
Ascites; Ascitic fluid; Ascitis; Baso; Basophil; Basos; Bph; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Peritoneal fluid; Point in time; Prt; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells |
2.79 |
2.07 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
31997-0 |
Biotin |
PrThr |
Bld |
Pt |
Ord |
|
|
ACTIVE |
Biotin [Presence] in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
31997-0 |
|
|
|
|
Both |
|
|
|
0 |
Biotin Bld Ql |
|
|
|
N |
|
Blood; Chemistry; Coenzyme R; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Vit H; Vitamin H; WB; Whole blood |
2.56 |
2.07 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
31998-8 |
Bordetella pertussis Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Bordetella pertussis Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
31998-8 |
|
|
|
|
Both |
|
|
|
0 |
B pert Ab Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B pert; B pertussis; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pertussis; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Whooping cough |
2.73 |
2.07 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
31999-6 |
Broad casts |
PrThr |
Urine sed |
Pt |
Ord |
Microscopy.light |
|
ACTIVE |
Broad casts [Presence] in Urine sediment by Light microscopy |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
UA |
|
31999-6 |
|
Microscopy.light |
|
|
Observation |
|
|
|
0 |
Broad Casts UrnS Ql Micro |
|
|
|
N |
|
Cast; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Renal; Renal failure casts; Screen; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS |
2.73 |
2.07 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
32-3 |
Ampicillin+Sulbactam |
Susc |
Isolate |
Pt |
OrdQn |
MIC |
|
ACTIVE |
Ampicillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
32-3 |
|
MIC |
|
|
Observation |
|
|
|
0 |
Ampicillin+Sulbac Islt MIC |
|
|
|
|
|
Amcil; Amicil; Amp; Ampicilloyl; ANTIBIOTIC SUSCEPTIBILITIES; AST; c203; c5; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Omnipen; Penbritin; Point in time; Polycillin; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Unasyn |
2.73 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
320-2 |
Methacycline |
Susc |
Isolate |
Pt |
OrdQn |
Agar diffusion |
|
ACTIVE |
Methacycline [Susceptibility] by Disk diffusion (KB) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
320-2 |
|
Agar diffusion |
|
|
Observation |
|
|
|
0 |
Methacycline Islt KB |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; Benciclina; Disk diffusion; Esarondil; Franciclina; Francomicinas; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Matamicina; Medomycin; Metacycline; Metadomus; Methylenecycline; Paveciclina; Physiomicine; Point in time; Quickmicina; Random; Rondomycin; Rotilen; Stafilon; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Treis-ciclina; Wassermicina |
2.19 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
3200-3 |
Coagulation factor VII activity actual/Normal |
SRto |
PPP |
Pt |
Qn |
Coag |
|
ACTIVE |
Coagulation factor VII activity actual/normal [Molar ratio] in Platelet poor plasma by Coagulation assay |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
COAG |
|
3200-3 |
|
Coag |
|
|
Both |
|
|
|
0 |
Fact VII Act/Nor PPP-sRto |
|
|
|
Y |
|
Act/Nor; Activ; Actvty; Clot; Clottable; Coag; Coagulation assay; Control; F7; Fac; Fact; Fact VII; Factor 7; FVII; Hematology; Heme; Movements; Plas; Platelet poor plasma; Point in time; Proconvertin; QNT; Quan; Quant; Quantitative; Random; Scrto; Serum prothrombin conversion accelerator; SPCA; Substance concentration ratio; Substance ratio; Tilt tube |
2.42 |
1 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
32000-2 |
Catecholamines |
MCnc |
Urine |
24H |
Qn |
|
|
ACTIVE |
Catecholamines [Mass/volume] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
CHEM |
|
32000-2 |
|
|
|
|
Both |
|
|
|
0 |
Catechols 24h Ur-mCnc |
|
|
|
N |
|
1 day; 24 hours; 24HR; Cate; Catec; Catech; Catechol; Catecholamine; Catecholamines.total; Catechols; Chemistry; Epinephrine+norepinephrine+dopamine; Level; Mass concentration; QNT; Quan; Quant; Quantitative; UA; UR; Urn |
2.73 |
2.07 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
32001-0 |
Chlamydia sp Ag |
PrThr |
Vag |
Pt |
Ord |
IA |
|
ACTIVE |
Chlamydia sp Ag [Presence] in Vaginal fluid by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
32001-0 |
|
IA |
|
|
Both |
|
|
|
0 |
Chlamydia Ag Vag Ql IA |
|
|
|
N |
|
Antigen; Antigens; Chlam; Chlamid; EIA; ELFA; ELISA; Enzyme immunoassay; Genital vaginal; Gyn; Gynecology; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; OB; ObGyn; Obstetrics; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; spp; SUDS; Vag fld; Vag fluid; Vagina; Vaginal fluid |
2.56 |
2.07 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
32002-8 |
Chlamydia sp Ag |
ACnc |
Penis |
Pt |
Ord |
EIA |
|
DEPRECATED |
Deprecated Chlamydia sp Ag [Presence] in Penis by Immunoassay |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
32002-8 |
|
EIA |
|
|
Both |
|
|
|
0 |
Deprecated Chlamydia Ag Penis Ql EIA |
|
|
|
N |
|
Antigen; Antigens; Arbitrary concentration; Chlam; Chlamid; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pen; Penile; Point in time; QL; Qual; Qualitative; Random; Screen; species; spp; SUDS |
2.52 |
2.07 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
32003-6 |
Chlamydia sp Ag |
PrThr |
Periton fld |
Pt |
Ord |
IA |
|
ACTIVE |
Chlamydia sp Ag [Presence] in Peritoneal fluid by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
32003-6 |
|
IA |
|
|
Both |
|
|
|
0 |
Chlamydia Ag Prt Ql IA |
|
|
|
N |
|
Antigen; Antigens; Ascites; Ascitic fluid; Ascitis; Chlam; Chlamid; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Peritoneal fluid; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; spp; SUDS |
2.56 |
2.07 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
32004-4 |
Chlamydia sp Ag |
PrThr |
Urine |
Pt |
Ord |
IA |
|
ACTIVE |
Chlamydia sp Ag [Presence] in Urine by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
32004-4 |
|
IA |
|
|
Both |
|
|
|
0 |
Chlamydia Ag Ur Ql IA |
|
|
|
N |
|
Antigen; Antigens; Chlam; Chlamid; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; spp; SUDS; UA; UR; Urn |
2.56 |
2.07 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
32005-1 |
Chlamydia trachomatis B Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Chlamydia trachomatis B Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
32005-1 |
|
|
|
|
Both |
|
|
|
0 |
C trach B Ab Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach B; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; Chlamydia trachomatis type B; CT; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Trachoma; Ttr |
2.75 |
2.07 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
32006-9 |
Chlamydia trachomatis C Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Chlamydia trachomatis C Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
32006-9 |
|
|
|
|
Both |
|
|
|
0 |
C trach C Ab Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach C; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; Chlamydia trachomatis type C; CT; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; Microbiology; Point in time; Random; Rh Blood Group System; Serum; SmQn; SR; Titer; Titered; Titre; Trachoma; Ttr |
2.75 |
2.07 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
32007-7 |
Chlamydia trachomatis G+F+K Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Chlamydia trachomatis G+F+K Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
32007-7 |
|
|
|
|
Both |
|
|
|
0 |
C trach G+F+K Ab Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach G+F+K; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; Chlamydia trachomatis type G+F+K; CT; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Intermediate; Kell Blood Group System; LGV; Lymphogranuloma venereum; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Trachoma; Ttr |
2.75 |
2.07 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
32008-5 |
Coproporphyrin/Creatinine |
SRto |
Urine |
24H |
Qn |
|
|
ACTIVE |
Coproporphyrin/Creatinine [Molar ratio] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
mmol/mol creatinine |
|
|
|
|
|
|
CHEM |
|
32008-5 |
|
|
|
|
Observation |
|
|
|
0 |
Copro/Creat 24h Ur-sRto |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; Copro; Coproporph; Coproporphyrins; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; Scrto; Substance concentration ratio; Substance ratio; Tetracarboxyl porphyrin; Tetracarboxylporphyrin; Tetracarboxylporphyrins; Tetracarboxyporphyrin; UA; UCr; UR; Urn |
2.42 |
2.07 |
|
|
|
|
|
|
|
mmol/mol{creat} |
|
|
|
0 |